Brawn Biotech's Q1 FY25 Financial Results Show Mixed Performance, Receives 'Sell' Call from MarketsMOJO

Aug 14 2024 11:49 PM IST
share
Share Via
Brawn Biotech, a microcap trading company, has released its financial results for the quarter ending March 2024. The company's net sales have shown a 54.21% increase year on year, indicating a strong sales trend. However, the debtors turnover ratio has slowed down, suggesting a need for caution when considering the company's stock.

Brawn Biotech, a microcap trading company, has recently announced its financial results for the quarter ending March 2024. The results, declared on August 14, 2024, have received a ‘Sell’ call from MarketsMOJO.

According to the financial report, Brawn Biotech has shown a flat performance in the quarter, with a score of 2 compared to -7 in the previous quarter. However, there are some positive and negative aspects to the company’s financials.


On the positive side, Brawn Biotech has seen a growth in net sales for the half-year period, with a 54.21% increase year on year. This indicates a strong sales trend in the near term.


On the other hand, the company’s debtors turnover ratio for the half-year period is at its lowest in the last five periods, at 1.55 times. This suggests that the company’s pace of settling its debtors has slowed down.


Overall, Brawn Biotech’s financial performance for the quarter ending March 2024 has been neutral, with some positive and negative aspects. Investors should carefully consider these factors before making any decisions regarding the company’s stock.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News